We hope you'll join us for our 4/23 webinar on using data tables to apply reference ranges and AE codes in OC4. For more information and to register, visit https://register.gotowebinar.com/register/2882170018956684555

Guidance on Groups

Dear OC users,
Do you have any guidance on how to use and edit groups?

Best regards,
Shmulik Adler
Project manager.
****************************************
A. Stein - Regulatory Affairs Consulting
Beit Hapaamon (Suite 102)
20 HaTaas Str. (P.O.B. 124)
Kfar Saba 44425 ISRAEL
Tel: +972-9-7670002
Fax: +972-9-7668534
E-mail: [email protected]
*****************************************
This message and any included attachments are from A. Stein - Regulatory
Affairs Consulting and are intended only for the addressee(s). The
information contained herein may include trade secrets or privileged or
otherwise confidential information. Unauthorized review, forwarding,
printing,copying, distributing, or using such information is strictly
prohibited and may be unlawful. If you received this message in error, or
have reason to believe you are not authorized to receive it, please promptly
delete this message and notify the sender by e-mail.

Attachments:
winmail.dat 2.6 KB

Comments

  • Hi Shmulik,

    Can you please specify whether you mean groups in a CRF, or Manage Groups in the Manage Study module of OpenClinica?

    Thanks,
    Paul
    Sent: Wednesday, August 20, 2008 5:06 AM
    To: [email protected]
    Subject: [Users] Guidance on Groups

    Dear OC users,
    Do you have any guidance on how to use and edit groups?

    Best regards,
    Shmulik Adler
    Project manager.
    ****************************************
    A. Stein - Regulatory Affairs Consulting
    Beit Hapaamon (Suite 102)
    20 HaTaas Str. (P.O.B. 124)
    Kfar Saba 44425 ISRAEL
    Tel: +972-9-7670002
    Fax: +972-9-7668534
    E-mail: [email protected]
    *****************************************
    This message and any included attachments are from A. Stein - Regulatory Affairs Consulting and are intended only for the addressee(s). The information contained herein may include trade secrets or privileged or otherwise confidential information. Unauthorized review, forwarding, printing,copying, distributing, or using such information is strictly prohibited and may be unlawful. If you received this message in error, or have reason to believe you are not authorized to receive it, please promptly delete this message and notify the sender by e-mail.
  • smadlersmadler Posts: 105
    Hi Paul,
    I meant what is exactly the use of groups in the CRF, but now that you mention the groups in the study module I would love to know for what it is and how to use them as well.
    Thanks,
    Shmulik
    Sent: Wednesday, August 20, 2008 4:43 PM
    To: [email protected]
    Subject: RE: [Users] Guidance on Groups
    Hi Shmulik,

    Can you please specify whether you mean groups in a CRF, or Manage Groups in the Manage Study module of OpenClinica?

    Thanks,
    Paul
    Sent: Wednesday, August 20, 2008 5:06 AM
    To: [email protected]
    Subject: [Users] Guidance on Groups

    Dear OC users,
    Do you have any guidance on how to use and edit groups?

    Best regards,
    Shmulik Adler
    Project manager.
    ****************************************
    A. Stein - Regulatory Affairs Consulting
    Beit Hapaamon (Suite 102)
    20 HaTaas Str. (P.O.B. 124)
    Kfar Saba 44425 ISRAEL
    Tel: +972-9-7670002
    Fax: +972-9-7668534
    E-mail: [email protected]
    *****************************************
    This message and any included attachments are from A. Stein - Regulatory Affairs Consulting and are intended only for the addressee(s). The information contained herein may include trade secrets or privileged or otherwise confidential information. Unauthorized review, forwarding, printing,copying, distributing, or using such information is strictly prohibited and may be unlawful. If you received this message in error, or have reason to believe you are not authorized to receive it, please promptly delete this message and notify the sender by e-mail.
This discussion has been closed.